Johnson & Johnson Stock Performance - Johnson & Johnson (JNJ) started 2024 at the same price as it started 2020, indicating no price appreciation over four years [1] - Despite a decent dividend, the lack of price appreciation makes the stock less attractive [1] Analyst Background - The analyst focuses on long-term investing through low-risk ETFs and CEFs [1] - The analyst has nearly ten years of experience trading stocks and currencies [1] - The analyst manages a family fund and invests in real estate [1] Disclosure and Disclaimer - The analyst has no stock, option, or derivative positions in the mentioned companies and no plans to initiate any within the next 72 hours [2] - The article expresses the analyst's own opinions and is not compensated by any company mentioned [2] - Seeking Alpha's disclosure states that past performance is no guarantee of future results and no investment advice is being given [3]
Johnson & Johnson: A Potential Beneficiary Of A Great Rotation